Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site.
Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site. Genes Dis. 2023 Mar; 10(2):310-312.